Bruna de Freitas Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bruna de Freitas Oliveira has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bruna Cunha Zaidan
Universidade Federal do Triângulo Mineiro, Brasil
1 shared publication - Crislaine Aparecida da Silva
Kidney Research Center, Universidade Federal do Triângulo Mineiro, Uberaba 38025-015, Brazil
1 shared publication - Juliana Reis Machado
Instituto de Ciências Biológicas e Naturais Universidade Federal do Triângulo Mineiro (UFTM) Uberaba MG Brazil
1 shared publication - Laura Penna Rocha
Kidney Research Center, Department of Pathology, Genetics and Evolution, Institute of Biological and Natural Sciences, Federal University of Triângulo Mineiro, Uberaba, Minas Gerais, Brazil
1 shared publication - Liliane Silvano Araújo
Kidney Research Center , Department of Pathology , Genetics and Evolution , Institute of Biological and Natural Sciences , Federal University of Triângulo Mineiro , Uberaba , Minas Gerais , Brazil , uftm.edu.br
1 shared publication - Marlene Antônia dos Reis
Department of General Pathology, School of Medicine, Federal University of Triângulo Mineiro, Uberaba, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , 9937801
Tissue Expression of NLRP3, IL‐1β, and IL‐18 in Glomerular and Interstitial Inflammation Associated With Diabetic Nephropathy
Activation of the NLRP3 inflammasome and its downstream cytokines IL‐1β and IL‐18 has been increasingly associated with the inflammatory mechanisms underlying diabetic nephropathy (DN), the leading cause of chronic kidney disease and end‐stage renal disease worldwide. This study investigated the expression of these inflammatory mediators in renal tissue from patients with DN. Eighty renal biopsies from adult patients (≥18 years) with a histopathological diagnosis of DN and 22 control samples obtained from autopsies were analyzed. NLRP3, IL‐1β, and IL‐18 expression was assessed by immunohistochemistry, and semi‐quantitative analysis was performed to determine the proportion of immunostained cells in the glomerular and interstitial compartments. A significant increase in immunostaining for all three mediators was observed in mesangial cells, podocytes, endothelial cells, and the interstitium of DN samples compared with controls ( p < 0.05). Positive and significant correlations were found between NLRP3 and IL‐1β in endothelial cells ( p < 0.0001; rS = 0.4720) and in the interstitium ( p = 0.0230; rS = 0.2540), as well as between NLRP3 and IL‐18 in podocytes ( p = 0.0055; rS = 0.3074). Moreover, interstitial expression of NLRP3 and IL‐1β correlated positively with serum creatinine levels ( p = 0.0015; rS = 0.3708; and p = 0.0029; rS = 0.3480, respectively), suggesting an association between inflammasome‐mediated inflammation and renal dysfunction. Collectively, these findings indicate that the NLRP3/IL‐1β/IL‐18 axis plays a central role in glomerular and interstitial injury in DN, supporting its potential as a prognostic biomarker and a promising therapeutic target for disease modulation.
- 1 January 2026
- Published by Wiley in Mediators of Inflammation
- Vol. 2026 (1) , 9937801
Open AccessTissue Expression of NLRP3, IL‐1β, and IL‐18 in Glomerular and Interstitial Inflammation Associated With Diabetic Nephropathy
Activation of the NLRP3 inflammasome and its downstream cytokines IL‐1β and IL‐18 has been increasingly associated with the inflammatory mechanisms underlying diabetic nephropathy (DN), the leading cause of chronic kidney disease and end‐stage renal disease worldwide. This study investigated the expression of these inflammatory mediators in renal tissue from patients with DN. Eighty renal biopsies from adult patients (≥18 years) with a histopathological diagnosis of DN and 22 control samples obtained from autopsies were analyzed. NLRP3, IL‐1β, and IL‐18 expression was assessed by immunohistochemistry, and semi‐quantitative analysis was performed to determine the proportion of immunostained cells in the glomerular and interstitial compartments. A significant increase in immunostaining for all three mediators was observed in mesangial cells, podocytes, endothelial cells, and the interstitium of DN samples compared with controls ( p < 0.05). Positive and significant correlations were found between NLRP3 and IL‐1β in endothelial cells ( p < 0.0001; rS = 0.4720) and in the interstitium ( p = 0.0230; rS = 0.2540), as well as between NLRP3 and IL‐18 in podocytes ( p = 0.0055; rS = 0.3074). Moreover, interstitial expression of NLRP3 and IL‐1β correlated positively with serum creatinine levels ( p = 0.0015; rS = 0.3708; and p = 0.0029; rS = 0.3480, respectively), suggesting an association between inflammasome‐mediated inflammation and renal dysfunction. Collectively, these findings indicate that the NLRP3/IL‐1β/IL‐18 axis plays a central role in glomerular and interstitial injury in DN, supporting its potential as a prognostic biomarker and a promising therapeutic target for disease modulation.